Nader Rifai is a Professor of Pathology at Harvard Medical School, the Louis Joseph Gay-Lussac Chair in Laboratory Medicine, and Director of Clinical Chemistry at Boston Children’s Hospital. His research focused on biomarkers of cardiovascular disease. However, in the last decade his main interest shifted to dissemination of scientific information and E-learning. Dr. Rifai is active in national and international societies; he served on the Board of Directors of the the Association for Diagnostics & Laboratory Medicine (formerly AACC), NACB and ABCC, was the Chair of Lipids and Lipoproteins Division, acted twice as the Vice-Chair of the the Association for Diagnostics & Laboratory Medicine (ADLM) annual meeting, and he is currently the Chair of the IFCC Visiting Lectureship programme and a member of the IFCC Education and Management Division. In addition, he is the Editor-in-Chief of Clinical Chemistry, the Founder and Co-Chair of Clinical Chemistry Trainee Council, the Senior Editor of Tietz Textbook of Clinical Chemistry and Molecular Diagnostics and the Co-Editor-in-Chief of NEJM Knowledge+/ADLM Learning Lab for Laboratory Medicine, an adaptive learning program.